Creating new value through prevention

「The group is using data developed through its pet insurance business, its veterinary medical network and genetic analysis technologies to support pets throughout a healthy and happy life, beginning before they join a family.」

「Upstream, the group is expanding breeder support through breeding that combines science, technology and data with medical support, as well as through the operation of matching websites. Midstream, it is expanding its health innovation business by promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu” and developing and selling oral and gut care products centred on the various tests. Downstream, it intends to commercialise and expand advanced veterinary medicine, including surgical support robots, cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand the scope of its pet-related businesses.」

「While continuing to centre its business on insurance, the group has established an organic portfolio that enables the agile introduction of new health promotion initiatives. This portfolio spans upstream “breeding and puppy and kitten matching support,” midstream “insurance with health checkups and the provision of oral and gut care products,” and downstream “medical care,” with these businesses also generating positive effects for the insurance business that has led the group to date.」

「The group is promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu,” developing and selling oral and gut care products centred on the various tests, and commercialising lifestyle consulting and other services. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand the scope of its pet-related businesses.」

「The group is accelerating initiatives for its second founding phase. To grow into a prevention-oriented insurance group that analyses illnesses and injuries using all available data and assesses “health,” it is accelerating efforts under its重点 initiatives for new businesses. In the genetic testing business, it seeks to prevent avoidable hereditary diseases through genetic testing of parents and offspring, and then provide breeding support by combining science, technology and data with medical support. It is also promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu,” commercialising and selling food centred on symbiotic bacteria, and commercialising lifestyle consulting and other services. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「In the breeding support business being developed across the group, the group has expanded and advanced initiatives to support breeders, including technology development to improve reproductive efficiency, such as the use of stem cells and frozen sperm, home-visit veterinary services to support medical care during breeding, the opening of animal handover centres called Kounotori to support the sale of animals, development of a breeding management system and provision of breeding facilities for lease. In particular, it has focused on the animal handover centres, opening 5 group-operated locations.」

「The group is accelerating initiatives for its second founding phase. To grow into a prevention-oriented insurance group that analyses illnesses and injuries using all available data and assesses “health,” it is accelerating efforts under its重点 initiatives for new businesses. In the genetic testing business, it seeks to prevent avoidable hereditary diseases through genetic testing of parents and offspring, and then provide breeding support by combining science, technology and data with medical support. It is also promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu,” commercialising and selling food centred on symbiotic bacteria, and commercialising lifestyle consulting and other services. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「In the genetic testing business, the group seeks to prevent avoidable hereditary diseases through genetic testing of parents and offspring, and then provide breeding support by combining science, technology and data, including genetic analysis, with medical support. It is also promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu,” commercialising and selling food centred on symbiotic bacteria, and commercialising lifestyle consulting and other services.」

「The group is accelerating initiatives for its second founding phase. To grow into a prevention-oriented insurance group that analyses illnesses and injuries using all available data and assesses “health,” it is accelerating efforts under its重点 initiatives for new businesses. In the genetic testing business, it seeks to prevent avoidable hereditary diseases through genetic testing of parents and offspring, and then provide breeding support by combining science, technology and data with medical support. It is also promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu,” commercialising and selling food centred on symbiotic bacteria, and commercialising lifestyle consulting and other services. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「The group is accelerating initiatives for its second founding phase. To grow into a prevention-oriented insurance group that analyses illnesses and injuries using all available data and assesses “health,” it is accelerating efforts under its重点 initiatives for new businesses. In the genetic testing business, it seeks to prevent avoidable hereditary diseases through genetic testing of parents and offspring, and then provide breeding support by combining science, technology and data with medical support. It is also promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu,” commercialising food development centred on symbiotic bacteria and lifestyle consulting. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「The group is accelerating initiatives for its second founding phase. To grow into a prevention-oriented insurance group that analyses illnesses and injuries using all available data and assesses “health,” it is accelerating efforts under its重点 initiatives for new businesses. In the genetic testing business, it seeks to prevent avoidable hereditary diseases through genetic testing of parents and offspring, and then provide breeding support by combining science, technology and data with medical support.」

「Beginning in fiscal 2019, the group positioned the period as its second founding phase and began initiatives to accelerate its progress and grow from an “insurance group that wipes away tears” into an “insurance group that creates smiles.” These initiatives involve using the extensive data obtained through its pet insurance business, including data on animals’ breeds, ages and diseases, together with genetic information obtained through its genetic testing business and the results of gut flora measurements provided as an ancillary service to insurance products. By analysing illnesses and injuries and assessing “health,” the group aims to prevent illness before it occurs and create smiles for pets and their owners.」

「In the genetic testing business, the group seeks to prevent avoidable hereditary diseases through genetic testing before and after breeding, and then provide breeding support by combining science, technology and data, including genetic analysis, with medical support. It is also promoting the wider adoption of animal health checks through “Doubutsu Kenkatsu,” commercialising food development centred on symbiotic bacteria, lifestyle consulting and other services. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「In the genetic testing business, the group seeks to prevent avoidable hereditary diseases through genetic testing before and after breeding, and then provide breeding support by combining science, technology and data, including genetic analysis, with medical support. It is also promoting the wider adoption of health checks for animals using gut flora measurements, commercialising food development centred on symbiotic bacteria, lifestyle consulting and other services. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「At Anicom Advanced Medical Research Institute Co., Ltd., the group conducts basic research in veterinary medicine, establishes evidence-based treatment methods, and undertakes research, clinical work and development aimed at developing preventive and advanced medical treatments. It also assumed responsibility for veterinary hospitals to support regional veterinary care. As a result, ordinary revenue for the first three months of the current consolidated fiscal year was ¥381 million, up 111.3% year on year. Anicom Advanced Medical Research Institute Co., Ltd. operates its own veterinary hospitals and provides primary and secondary care, from prevention onward. It aims to establish next-generation preventive methods by using medical and other data obtained through this process.」

「In the genetic testing business, the group seeks to prevent avoidable hereditary diseases through genetic testing before and after breeding, and then provide breeding support by combining science, technology and data, including genetic analysis, with medical support. It is also promoting the wider adoption of health checks for animals using gut flora measurements, commercialising food development centred on symbiotic bacteria, lifestyle consulting and other services. In addition, it intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「Beginning in December 2018, the group launched “Doubutsu Kenkatsu,” its proprietary service aimed at making Anicom Group a “prevention-oriented insurer.” The service assesses the likelihood of illness based on the results of a pet’s gut flora measurement and provides a free health checkup based on the results.」

「Regarding the other重点 initiative, “strengthening efforts toward prevention (making the fruits of new businesses tangible),” the group has undertaken numerous initiatives to date. It continues these efforts by using the people, facilities and data in which it has invested, with the aim of eliminating as many diseases as possible as quickly as possible. In particular, to eradicate hereditary diseases, it provides breeding support that combines science, technology and data, including genetic analysis, with medical support. It is also promoting the wider adoption of health checks for animals using gut flora measurements, commercialising food development centred on symbiotic bacteria, lifestyle consulting and other services. In addition, it intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「Regarding the other重点 initiative, “strengthening efforts toward prevention (making the fruits of new businesses tangible),” the group has undertaken numerous initiatives to date. It continues these efforts by using the people, facilities and data in which it has invested, with the aim of eliminating as many diseases as possible as quickly as possible.」

「Regarding the other重点 initiative, “strengthening efforts toward prevention (making the fruits of new businesses tangible),” the group has undertaken numerous initiatives to date. It continues these efforts by using the people, facilities and data in which it has invested, with the aim of eliminating as many diseases as possible as quickly as possible. In particular, to eradicate hereditary diseases, it provides breeding support that combines science, technology and data, including genetic analysis, with medical support. It is also promoting the wider adoption of health checks for animals using gut flora measurements, commercialising food development centred on symbiotic bacteria, lifestyle consulting and other services. In addition, it intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, it aims to develop preventive methods through further use of data and expand its pet-related businesses overseas.」

「The group has world-class research data on pet gut flora testing, which it has conducted for many years. By combining these results with its database on pets’ lifestyles, it intends to commercialise health checkups based on gut flora testing, food development centred on symbiotic bacteria, lifestyle consulting and other services, and generate revenue. It also intends to commercialise and expand advanced veterinary medicine, including cell therapy and regenerative medicine. Together with expanding its medical records management system business, including enhanced functions such as appointment scheduling, the group aims to develop preventive methods through further use of data and expand its pet-related businesses overseas, thereby contributing to the development of veterinary medicine.」

「Regarding the other key initiative, “strengthening efforts toward prevention,” the company is utilizing the personnel, facilities and data in which it has invested to date. In particular, it advanced preparations to launch a genetic testing business aimed at eradicating genetic diseases. It is also conducting research into breeding support aimed at eliminating genetic diseases, preventive measures for disease onset centered on symbiotic bacteria, and various other preventive measures aimed at extending the healthy lifespans of animals.」

「Regarding the other key initiative, “strengthening efforts toward prevention,” the company is utilizing the personnel, facilities and data in which it has invested to date. In particular, it advanced preparations to launch a genetic testing business aimed at eradicating genetic diseases. It is also conducting research into breeding support aimed at eliminating genetic diseases, preventive measures for disease onset centered on symbiotic bacteria, and various other preventive measures aimed at extending the healthy lifespans of animals.」

「Regarding the other key initiative, “strengthening efforts toward prevention,” the company is utilizing the personnel, facilities and data in which it has invested to date. In particular, it advanced preparations to launch a genetic testing business aimed at eradicating genetic diseases. It is also conducting research into breeding support aimed at eliminating genetic diseases, preventive measures for disease onset centered on symbiotic bacteria, and various other preventive measures aimed at extending the healthy lifespans of animals.」

「In particular, by stepping up efforts to eradicate genetic diseases, the company will develop testing businesses such as analyses of disease-related genes and provide breeding support aimed at eliminating genetic diseases, while continuing research into preventing disease onset with symbiotic bacteria as a key focus and working toward commercialization. In addition, it aims to establish next-generation preventive methods and reduce insurance claims payments by using big data, including medical data accessed through Anicom Pafe Co., Ltd.'s “AniColesepter” and insurance claims data held by Anicom General Insurance.」

「Regarding the other key initiative, “providing new value through prevention,” the company aims to extend the healthy lifespans of animals and their owners. Across the group, it is actively pursuing multifaceted research and developing new businesses to deploy measures that help improve the prognosis of animal diseases, prevent recurrence and prevent onset, by scientifically and epidemiologically analyzing insurance claims data, medical record data and other data accumulated by the group to date.」

「As セルトラスト・アニマル・セラピューティクス Co., Ltd. was newly established, it has been included as an equity-method affiliate from the current interim consolidated accounting period.」

「Across the group, the company is actively pursuing multifaceted research and developing new businesses to deploy measures that help improve the prognosis of animal diseases, prevent recurrence and prevent onset, by scientifically and epidemiologically analyzing insurance claims data, medical record data and other data accumulated by the group to date.」